<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2020-10-07" version="200">
<accession>Q14653</accession>
<accession>A8K7L2</accession>
<accession>B2RAZ3</accession>
<accession>Q5FBY1</accession>
<accession>Q5FBY2</accession>
<accession>Q5FBY4</accession>
<accession>Q7Z5G6</accession>
<name>IRF3_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="53 54">Interferon regulatory factor 3</fullName>
<shortName evidence="53">IRF-3</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary" evidence="54 58">IRF3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Proc. Natl. Acad. Sci. U.S.A." volume="92" first="11657" last="11661">
<title>Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes.</title>
<authorList>
<person name="Au W.W.-C."/>
<person name="Moore P.P.A."/>
<person name="Lowther W.W."/>
<person name="Juang Y.-T."/>
<person name="Pitha P.M."/>
</authorList>
<dbReference type="PubMed" id="8524823"/>
<dbReference type="DOI" id="10.1073/pnas.92.25.11657"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Retina</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2003-02" db="EMBL/GenBank/DDBJ databases">
<title>IRF3 mRNA, nirs splice variants.</title>
<authorList>
<person name="Tabata Y."/>
<person name="Sameshima E."/>
<person name="Hayashi A."/>
<person name="Iida K."/>
<person name="Mitsuyama M."/>
<person name="Kanai S."/>
<person name="Furuya T."/>
<person name="Saito T."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 5)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT THR-427</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT THR-427</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4)</scope>
<source>
<tissue>Eye</tissue>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="Ann. Hum. Genet." volume="62" first="231" last="234">
<title>Mapping of human interferon regulatory factor 3 (IRF3) to chromosome 19q13.3-13.4 by an intragenic polymorphic marker.</title>
<authorList>
<person name="Bellingham J."/>
<person name="Gregory-Evans K."/>
<person name="Gregory-Evans C.Y."/>
</authorList>
<dbReference type="PubMed" id="9803267"/>
<dbReference type="DOI" id="10.1046/j.1469-1809.1998.6230231.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 323-413</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="2986" last="2996">
<title>Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation.</title>
<authorList>
<person name="Lin R."/>
<person name="Heylbroeck C."/>
<person name="Pitha P.M."/>
<person name="Hiscott J."/>
</authorList>
<dbReference type="PubMed" id="9566918"/>
<dbReference type="DOI" id="10.1128/mcb.18.5.2986"/>
</citation>
<scope>MUTAGENESIS OF 385-SER-SER-386 AND 396-SER--SER-405</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="J. Biochem." volume="128" first="301" last="307">
<title>Analyses of virus-induced homomeric and heteromeric protein associations between IRF-3 and coactivator CBP/p300.</title>
<authorList>
<person name="Suhara W."/>
<person name="Yoneyama M."/>
<person name="Iwamura T."/>
<person name="Yoshimura S."/>
<person name="Tamura K."/>
<person name="Namiki H."/>
<person name="Aimoto S."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="10920266"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.jbchem.a022753"/>
</citation>
<scope>MUTAGENESIS OF SER-385 AND SER-386</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="4159" last="4168">
<title>Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1.</title>
<authorList>
<person name="Kumar K.P."/>
<person name="McBride K.M."/>
<person name="Weaver B.K."/>
<person name="Dingwall C."/>
<person name="Reich N.C."/>
</authorList>
<dbReference type="PubMed" id="10805757"/>
<dbReference type="DOI" id="10.1128/mcb.20.11.4159-4168.2000"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 77-LYS-ARG-78; 86-ARG-LYS-87 AND 139-ILE-LEU-140</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="355" last="363">
<title>Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3.</title>
<authorList>
<person name="Servant M.J."/>
<person name="ten Oever B."/>
<person name="LePage C."/>
<person name="Conti L."/>
<person name="Gessani S."/>
<person name="Julkunen I."/>
<person name="Lin R."/>
<person name="Hiscott J."/>
</authorList>
<dbReference type="PubMed" id="11035028"/>
<dbReference type="DOI" id="10.1074/jbc.m007790200"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="8951" last="8957">
<title>IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein.</title>
<authorList>
<person name="Smith E.J."/>
<person name="Marie I.J."/>
<person name="Prakash A."/>
<person name="Garcia-Sastre A."/>
<person name="Levy D.E."/>
</authorList>
<dbReference type="PubMed" id="11124948"/>
<dbReference type="DOI" id="10.1074/jbc.m008717200"/>
</citation>
<scope>INHIBITION OF PHOSPHORYLATION BY VACCINIA VIRUS PROTEIN E3 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="800" last="811">
<title>HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators.</title>
<authorList>
<person name="Lin R."/>
<person name="Genin P."/>
<person name="Mamane Y."/>
<person name="Sgarbanti M."/>
<person name="Battistini A."/>
<person name="Harrington W.J. Jr."/>
<person name="Barber G.N."/>
<person name="Hiscott J."/>
</authorList>
<dbReference type="PubMed" id="11314014"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204163"/>
</citation>
<scope>INTERACTION WITH HHV-8 PROTEIN VIRF1 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="J. Interferon Cytokine Res." volume="22" first="73" last="76">
<title>Control of IRF-3 activation by phosphorylation.</title>
<authorList>
<person name="Yoneyama M."/>
<person name="Suhara W."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="11846977"/>
<dbReference type="DOI" id="10.1089/107999002753452674"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="J. Immunol." volume="169" first="6668" last="6672">
<title>A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.</title>
<authorList>
<person name="Yamamoto M."/>
<person name="Sato S."/>
<person name="Mori K."/>
<person name="Hoshino K."/>
<person name="Takeuchi O."/>
<person name="Takeda K."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="12471095"/>
<dbReference type="DOI" id="10.4049/jimmunol.169.12.6668"/>
</citation>
<scope>INTERACTION WITH TICAM1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="J. Virol." volume="76" first="9545" last="9550">
<title>Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1.</title>
<authorList>
<person name="Graff J.W."/>
<person name="Mitzel D.N."/>
<person name="Weisend C.M."/>
<person name="Flenniken M.L."/>
<person name="Hardy M.E."/>
</authorList>
<dbReference type="PubMed" id="12186937"/>
<dbReference type="DOI" id="10.1128/jvi.76.18.9545-9550.2002"/>
</citation>
<scope>INTERACTION WITH ROTAVIRUS A NSP1 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="J. Exp. Med." volume="198" first="1043" last="1055">
<title>LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.</title>
<authorList>
<person name="Fitzgerald K.A."/>
<person name="Rowe D.C."/>
<person name="Barnes B.J."/>
<person name="Caffrey D.R."/>
<person name="Visintin A."/>
<person name="Latz E."/>
<person name="Monks B."/>
<person name="Pitha P.M."/>
<person name="Golenbock D.T."/>
</authorList>
<dbReference type="PubMed" id="14517278"/>
<dbReference type="DOI" id="10.1084/jem.20031023"/>
</citation>
<scope>INTERACTION WITH TICAM2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2003" name="J. Exp. Med." volume="198" first="1451" last="1451">
<authorList>
<person name="Fitzgerald K.A."/>
<person name="Rowe D.C."/>
<person name="Barnes B.J."/>
<person name="Caffrey D.R."/>
<person name="Visintin A."/>
<person name="Latz E."/>
<person name="Monks B."/>
<person name="Pitha P.M."/>
<person name="Golenbock D.T."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:14517278</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="Science" volume="300" first="1148" last="1151">
<title>Triggering the interferon antiviral response through an IKK-related pathway.</title>
<authorList>
<person name="Sharma S."/>
<person name="tenOever B.R."/>
<person name="Grandvaux N."/>
<person name="Zhou G.-P."/>
<person name="Lin R."/>
<person name="Hiscott J."/>
</authorList>
<dbReference type="PubMed" id="12702806"/>
<dbReference type="DOI" id="10.1126/science.1081315"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="15652" last="15661">
<title>Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.</title>
<authorList>
<person name="Han K.J."/>
<person name="Su X."/>
<person name="Xu L.-G."/>
<person name="Bin L.H."/>
<person name="Zhang J."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="14739303"/>
<dbReference type="DOI" id="10.1074/jbc.m311629200"/>
</citation>
<scope>INTERACTION WITH TICAM1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="4018" last="4028">
<title>SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.</title>
<authorList>
<person name="Huang J."/>
<person name="Liu T."/>
<person name="Xu L.-G."/>
<person name="Chen D."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="16281057"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600863"/>
</citation>
<scope>INTERACTION WITH IKBKE AND TBK1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="Mol. Cell" volume="19" first="727" last="740">
<title>VISA is an adapter protein required for virus-triggered IFN-beta Signaling.</title>
<authorList>
<person name="Xu L.-G."/>
<person name="Wang Y.-Y."/>
<person name="Han K.-J."/>
<person name="Li L.-Y."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="16153868"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.08.014"/>
</citation>
<scope>INTERACTION WITH MAVS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="Biochem. Pharmacol." volume="72" first="1469" last="1476">
<title>Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages.</title>
<authorList>
<person name="Solis M."/>
<person name="Goubau D."/>
<person name="Romieu-Mourez R."/>
<person name="Genin P."/>
<person name="Civas A."/>
<person name="Hiscott J."/>
</authorList>
<dbReference type="PubMed" id="16846591"/>
<dbReference type="DOI" id="10.1016/j.bcp.2006.06.002"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Immunity" volume="25" first="349" last="360">
<title>Type I interferon gene induction by the interferon regulatory factor family of transcription factors.</title>
<authorList>
<person name="Honda K."/>
<person name="Takaoka A."/>
<person name="Taniguchi T."/>
</authorList>
<dbReference type="PubMed" id="16979567"/>
<dbReference type="DOI" id="10.1016/j.immuni.2006.08.009"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="Immunity" volume="25" first="849" last="849">
<authorList>
<person name="Honda K."/>
<person name="Takaoka A."/>
<person name="Taniguchi T."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:16979567</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Cell Res." volume="18" first="1096" last="1104">
<title>Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3.</title>
<authorList>
<person name="Zhang M."/>
<person name="Tian Y."/>
<person name="Wang R.P."/>
<person name="Gao D."/>
<person name="Zhang Y."/>
<person name="Diao F.C."/>
<person name="Chen D.Y."/>
<person name="Zhai Z.H."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="18711448"/>
<dbReference type="DOI" id="10.1038/cr.2008.277"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH RBCK1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="J. Immunol." volume="181" first="1780" last="1786">
<title>The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3.</title>
<authorList>
<person name="Higgs R."/>
<person name="Ni Gabhann J."/>
<person name="Ben Larbi N."/>
<person name="Breen E.P."/>
<person name="Fitzgerald K.A."/>
<person name="Jefferies C.A."/>
</authorList>
<dbReference type="PubMed" id="18641315"/>
<dbReference type="DOI" id="10.4049/jimmunol.181.3.1780"/>
</citation>
<scope>INTERACTION WITH TRIM21</scope>
<scope>POLYUBIQUITINATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="J. Virol." volume="83" first="3069" last="3077">
<title>Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1.</title>
<authorList>
<person name="Prins K.C."/>
<person name="Cardenas W.B."/>
<person name="Basler C.F."/>
</authorList>
<dbReference type="PubMed" id="19153231"/>
<dbReference type="DOI" id="10.1128/jvi.01875-08"/>
</citation>
<scope>PHOSPHORYLATION BY IKBKE AND TBK1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Mol. Cell. Biochem." volume="332" first="113" last="120">
<title>RIOK3 interacts with caspase-10 and negatively regulates the NF-kappaB signaling pathway.</title>
<authorList>
<person name="Shan J."/>
<person name="Wang P."/>
<person name="Zhou J."/>
<person name="Wu D."/>
<person name="Shi H."/>
<person name="Huo K."/>
</authorList>
<dbReference type="PubMed" id="19557502"/>
<dbReference type="DOI" id="10.1007/s11010-009-0180-8"/>
</citation>
<scope>INTERACTION WITH RIOK3</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="Cancer Immunol. Immunother." volume="59" first="489" last="510">
<title>Regulation of immunity and oncogenesis by the IRF transcription factor family.</title>
<authorList>
<person name="Savitsky D."/>
<person name="Tamura T."/>
<person name="Yanai H."/>
<person name="Taniguchi T."/>
</authorList>
<dbReference type="PubMed" id="20049431"/>
<dbReference type="DOI" id="10.1007/s00262-009-0804-6"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="2424" last="2436">
<title>Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification.</title>
<authorList>
<person name="Shi H.X."/>
<person name="Yang K."/>
<person name="Liu X."/>
<person name="Liu X.Y."/>
<person name="Wei B."/>
<person name="Shan Y.F."/>
<person name="Zhu L.H."/>
<person name="Wang C."/>
</authorList>
<dbReference type="PubMed" id="20308324"/>
<dbReference type="DOI" id="10.1128/mcb.01466-09"/>
</citation>
<scope>ISGYLATION AT LYS-193; LYS-360 AND LYS-366</scope>
<scope>MUTAGENESIS OF LYS-193; LYS-360 AND LYS-366</scope>
<scope>INTERACTION WITH HERC5</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2012" name="Sci. Signal." volume="5" first="RA20" last="RA20">
<title>STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway.</title>
<authorList>
<person name="Tanaka Y."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="22394562"/>
<dbReference type="DOI" id="10.1126/scisignal.2002521"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH STING1</scope>
<scope>PHOSPHORYLATION AT SER-385; SER-386 AND SER-396</scope>
<scope>MUTAGENESIS OF SER-385 AND SER-386</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="2004" last="2015">
<title>Human DEAD box helicase 3 couples IkappaB kinase epsilon to interferon regulatory factor 3 activation.</title>
<authorList>
<person name="Gu L."/>
<person name="Fullam A."/>
<person name="Brennan R."/>
<person name="Schroder M."/>
</authorList>
<dbReference type="PubMed" id="23478265"/>
<dbReference type="DOI" id="10.1128/mcb.01603-12"/>
</citation>
<scope>INTERACTION WITH DDX3X AND IKBKE</scope>
<scope>PHOSPHORYLATION AT SER-396</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2013" name="Structure" volume="21" first="1137" last="1148">
<title>Structural insights into the functions of TBK1 in innate antimicrobial immunity.</title>
<authorList>
<person name="Shu C."/>
<person name="Sankaran B."/>
<person name="Chaton C.T."/>
<person name="Herr A.B."/>
<person name="Mishra A."/>
<person name="Peng J."/>
<person name="Li P."/>
</authorList>
<dbReference type="PubMed" id="23746807"/>
<dbReference type="DOI" id="10.1016/j.str.2013.04.025"/>
</citation>
<scope>PHOSPHORYLATION AT THR-3; SER-14; THR-75; SER-97; THR-180; SER-188; THR-237; THR-244; THR-253; SER-398; THR-404 AND SER-427</scope>
<scope>PHOSPHORYLATION AT SER-386 BY TBK1</scope>
<scope>MUTAGENESIS OF SER-386</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2015" name="J. Cell Biol." volume="210" first="973" last="989">
<title>TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity.</title>
<authorList>
<person name="Kimura T."/>
<person name="Jain A."/>
<person name="Choi S.W."/>
<person name="Mandell M.A."/>
<person name="Schroder K."/>
<person name="Johansen T."/>
<person name="Deretic V."/>
</authorList>
<dbReference type="PubMed" id="26347139"/>
<dbReference type="DOI" id="10.1083/jcb.201503023"/>
</citation>
<scope>HOMODIMERIZATION</scope>
<scope>INTERACTION WITH TRIM21 AND ULK1</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2017" name="Biochem. J." volume="474" first="571" last="587">
<title>DDX3 directly regulates TRAF3 ubiquitination and acts as a scaffold to co-ordinate assembly of signalling complexes downstream from MAVS.</title>
<authorList>
<person name="Gu L."/>
<person name="Fullam A."/>
<person name="McCormack N."/>
<person name="Hoehn Y."/>
<person name="Schroeder M."/>
</authorList>
<dbReference type="PubMed" id="27980081"/>
<dbReference type="DOI" id="10.1042/bcj20160956"/>
</citation>
<scope>INTERACTION WITH DDX3X AND TRAF3</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2017" name="Leukemia" volume="31" first="1470" last="1473">
<title>ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma.</title>
<authorList>
<person name="Dzikiewicz-Krawczyk A."/>
<person name="Kok K."/>
<person name="Slezak-Prochazka I."/>
<person name="Robertus J.L."/>
<person name="Bruining J."/>
<person name="Tayari M.M."/>
<person name="Rutgers B."/>
<person name="de Jong D."/>
<person name="Koerts J."/>
<person name="Seitz A."/>
<person name="Li J."/>
<person name="Tillema B."/>
<person name="Guikema J.E."/>
<person name="Nolte I.M."/>
<person name="Diepstra A."/>
<person name="Visser L."/>
<person name="Kluiver J."/>
<person name="van den Berg A."/>
</authorList>
<dbReference type="PubMed" id="28331227"/>
<dbReference type="DOI" id="10.1038/leu.2017.94"/>
</citation>
<scope>INTERACTION WITH STING1 AND ZDHHC11</scope>
<scope>REGION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2018" name="J. Biol. Chem." volume="293" first="10561" last="10573">
<title>C6orf106 is a novel inhibitor of the interferon-regulatory factor 3-dependent innate antiviral response.</title>
<authorList>
<person name="Ambrose R.L."/>
<person name="Liu Y.C."/>
<person name="Adams T.E."/>
<person name="Bean A.G.D."/>
<person name="Stewart C.R."/>
</authorList>
<dbReference type="PubMed" id="29802199"/>
<dbReference type="DOI" id="10.1074/jbc.ra117.001491"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION BY DSRNA</scope>
<scope>INTERACTION WITH IRF3</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2018" name="Virology" volume="518" first="1" last="7">
<title>Seneca Valley Virus 3Cpro abrogates the IRF3- and IRF7-mediated innate immune response by degrading IRF3 and IRF7.</title>
<authorList>
<person name="Xue Q."/>
<person name="Liu H."/>
<person name="Zhu Z."/>
<person name="Yang F."/>
<person name="Ma L."/>
<person name="Cai X."/>
<person name="Xue Q."/>
<person name="Zheng H."/>
</authorList>
<dbReference type="PubMed" id="29427864"/>
<dbReference type="DOI" id="10.1016/j.virol.2018.01.028"/>
</citation>
<scope>INTERACTION WITH SENECA VALLEY VIRUS PROTEASE 3C (MICROBIAL INFECTION)</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2015" name="J. Exp. Med." volume="212" first="1371" last="1379">
<title>Functional IRF3 deficiency in a patient with herpes simplex encephalitis.</title>
<authorList>
<person name="Andersen L.L."/>
<person name="Moerk N."/>
<person name="Reinert L.S."/>
<person name="Kofod-Olsen E."/>
<person name="Narita R."/>
<person name="Joergensen S.E."/>
<person name="Skipper K.A."/>
<person name="Hoening K."/>
<person name="Gad H.H."/>
<person name="Oestergaard L."/>
<person name="Oerntoft T.F."/>
<person name="Hornung V."/>
<person name="Paludan S.R."/>
<person name="Mikkelsen J.G."/>
<person name="Fujita T."/>
<person name="Christiansen M."/>
<person name="Hartmann R."/>
<person name="Mogensen T.H."/>
</authorList>
<dbReference type="PubMed" id="26216125"/>
<dbReference type="DOI" id="10.1084/jem.20142274"/>
</citation>
<scope>INVOLVEMENT IN IIAE7</scope>
<scope>VARIANT IIAE7 GLN-285</scope>
<scope>CHARACTERIZATION OF VARIANT IIAE7 GLN-285</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2015" name="Science" volume="347" first="AAA2630" last="AAA2630">
<title>Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation.</title>
<authorList>
<person name="Liu S."/>
<person name="Cai X."/>
<person name="Wu J."/>
<person name="Cong Q."/>
<person name="Chen X."/>
<person name="Li T."/>
<person name="Du F."/>
<person name="Ren J."/>
<person name="Wu Y.T."/>
<person name="Grishin N.V."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="25636800"/>
<dbReference type="DOI" id="10.1126/science.aaa2630"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>INTERACTION WITH STING1; MAVS AND TICAM1</scope>
<scope>PHOSPHORYLATION AT SER-385; SER-386 AND SER-396</scope>
<scope>MUTAGENESIS OF SER-385 AND SER-386</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2019" name="J. Virol.">
<title>LYAR suppresses interferon-beta induction by targeting phosphorylated IRF3.</title>
<authorList>
<person name="Yang C."/>
<person name="Liu X."/>
<person name="Cheng T."/>
<person name="Xiao R."/>
<person name="Gao Q."/>
<person name="Ming F."/>
<person name="Jin M."/>
<person name="Chen H."/>
<person name="Zhou H."/>
</authorList>
<dbReference type="PubMed" id="31413131"/>
<dbReference type="DOI" id="10.1128/jvi.00769-19"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH LYAR</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2003" name="Nat. Struct. Biol." volume="10" first="922" last="927">
<title>X-ray crystal structure of IRF-3 and its functional implications.</title>
<authorList>
<person name="Takahasi K."/>
<person name="Suzuki N.N."/>
<person name="Horiuchi M."/>
<person name="Mori M."/>
<person name="Suhara W."/>
<person name="Okabe Y."/>
<person name="Fukuhara Y."/>
<person name="Terasawa H."/>
<person name="Akira S."/>
<person name="Fujita T."/>
<person name="Inagaki F."/>
</authorList>
<dbReference type="PubMed" id="14555995"/>
<dbReference type="DOI" id="10.1038/nsb1001"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 175-427</scope>
<scope>DISULFIDE BOND</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2003" name="Nat. Struct. Biol." volume="10" first="913" last="921">
<title>Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation.</title>
<authorList>
<person name="Qin B.Y."/>
<person name="Liu C."/>
<person name="Lam S.S."/>
<person name="Srinath H."/>
<person name="Delston R."/>
<person name="Correia J.J."/>
<person name="Derynck R."/>
<person name="Lin K."/>
</authorList>
<dbReference type="PubMed" id="14555996"/>
<dbReference type="DOI" id="10.1038/nsb1002"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 173-427</scope>
<scope>DISULFIDE BOND</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="4384" last="4393">
<title>Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer.</title>
<authorList>
<person name="Panne D."/>
<person name="Maniatis T."/>
<person name="Harrison S.C."/>
</authorList>
<dbReference type="PubMed" id="15510218"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600453"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 1-112</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2005" name="Structure" volume="13" first="1269" last="1277">
<title>Crystal structure of IRF-3 in complex with CBP.</title>
<authorList>
<person name="Qin B.Y."/>
<person name="Liu C."/>
<person name="Srinath H."/>
<person name="Lam S.S."/>
<person name="Correia J.J."/>
<person name="Derynck R."/>
<person name="Lin K."/>
</authorList>
<dbReference type="PubMed" id="16154084"/>
<dbReference type="DOI" id="10.1016/j.str.2005.06.011"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 173-394</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CREBBP</scope>
</reference>
<reference key="49" evidence="7 8 9 10 11 12">
<citation type="journal article" date="2016" name="Proc. Natl. Acad. Sci. U.S.A." volume="113" first="E3403" last="E3412">
<title>Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins.</title>
<authorList>
<person name="Zhao B."/>
<person name="Shu C."/>
<person name="Gao X."/>
<person name="Sankaran B."/>
<person name="Du F."/>
<person name="Shelton C.L."/>
<person name="Herr A.B."/>
<person name="Ji J.Y."/>
<person name="Li P."/>
</authorList>
<dbReference type="PubMed" id="27302953"/>
<dbReference type="DOI" id="10.1073/pnas.1603269113"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 189-427 IN COMPLEX WITH CREBBP; MAVS; STING1 OR TICAM1</scope>
<scope>X-RAY CRYSTALLOGRAPHY (2.91 ANGSTROMS) OF 189-427 IN COMPLEX WITH ROTAVIRUS A NSP1 (MICROBIAL INFECTION)</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>INTERACTION WITH CREBBP; MAVS; STING1 AND TICAM1</scope>
<scope>INTERACTION WITH ROTAVIRUS A NSP1 (MICROBIAL INFECTION)</scope>
<scope>PHOSPHORYLATION AT SER-386 AND SER-396</scope>
<scope>MUTAGENESIS OF ARG-285; HIS-288; HIS-290; LYS-313; SER-386 AND SER-396</scope>
</reference>
<comment type="function">
<text evidence="28 34 37 40 45 48 50 51 52">Key transcriptional regulator of type I interferon (IFN)-dependent immune responses which plays a critical role in the innate immune response against DNA and RNA viruses (PubMed:22394562, PubMed:25636800, PubMed:27302953). Regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters (PubMed:11846977, PubMed:16846591, PubMed:16979567, PubMed:20049431). Acts as a more potent activator of the IFN-beta (IFNB) gene than the IFN-alpha (IFNA) gene and plays a critical role in both the early and late phases of the IFNA/B gene induction (PubMed:16846591, PubMed:16979567, PubMed:20049431). Found in an inactive form in the cytoplasm of uninfected cells and following viral infection, double-stranded RNA (dsRNA), or toll-like receptor (TLR) signaling, is phosphorylated by IKBKE and TBK1 kinases (PubMed:22394562, PubMed:25636800, PubMed:27302953). This induces a conformational change, leading to its dimerization and nuclear localization and association with CREB binding protein (CREBBP) to form dsRNA-activated factor 1 (DRAF1), a complex which activates the transcription of the type I IFN and ISG genes (PubMed:16154084, PubMed:27302953). Can activate distinct gene expression programs in macrophages and can induce significant apoptosis in primary macrophages (PubMed:16846591).</text>
</comment>
<comment type="activity regulation">
<text evidence="37 40 50 51 52">In the absence of viral infection, maintained as a monomer in an autoinhibited state (PubMed:16846591, PubMed:16979567, PubMed:20049431). Phosphorylation by TBK1 and IKBKE disrupts this autoinhibition leading to the liberation of the DNA-binding and dimerization activities and its nuclear localization where it can activate type I IFN and ISG genes (PubMed:25636800). Phosphorylation and activation follow the following steps: innate adapter protein MAVS, STING1 or TICAM1 are first activated by viral RNA, cytosolic DNA and bacterial lipopolysaccharide (LPS), respectively, leading to activation of the kinases TBK1 and IKBKE (PubMed:25636800). These kinases then phosphorylate the adapter proteins on their pLxIS motif, leading to recruitment of IRF3, thereby licensing IRF3 for phosphorylation by TBK1 (PubMed:25636800). Phosphorylated IRF3 dissociates from the adapter proteins, dimerizes, and then enters the nucleus to induce IFNs (PubMed:25636800, PubMed:27302953).</text>
</comment>
<comment type="subunit">
<text evidence="21 22 26 27 28 29 30 31 32 33 34 35 37 39 40 41 42 44 45 50 51 52">Monomer (PubMed:16846591, PubMed:16979567, PubMed:20049431). Homodimer; phosphorylation-induced (PubMed:22394562, PubMed:25636800, PubMed:26347139). Interacts (when phosphorylated) with CREBBP (PubMed:16154084, PubMed:27302953). Interacts with MAVS (via phosphorylated pLxIS motif) (PubMed:16153868, PubMed:25636800, PubMed:27302953). Interacts with TICAM1 (via phosphorylated pLxIS motif) (PubMed:12471095, PubMed:14739303, PubMed:25636800, PubMed:27302953). Interacts with STING1 (via phosphorylated pLxIS motif) (PubMed:22394562, PubMed:28331227, PubMed:25636800, PubMed:27302953). Interacts with IKBKE and TBK1 (PubMed:16281057, PubMed:23478265, PubMed:25636800). Interacts with TICAM2 (PubMed:14517278). Interacts with RBCK1 (PubMed:18711448). Interacts with HERC5 (PubMed:20308324). Interacts with DDX3X (phosphorylated at 'Ser-102'); the interaction allows the phosphorylation and activation of IRF3 by IKBKE (PubMed:23478265, PubMed:27980081). Interacts with TRIM21 and ULK1, in the presence of TRIM21; this interaction leads to IRF3 degradation by autophagy (PubMed:18641315, PubMed:26347139). Interacts with RIOK3; RIOK3 probably mediates the interaction of TBK1 with IRF3 (PubMed:19557502). Interacts with ILRUN; the interaction inhibits IRF3 binding to its DNA consensus sequence (PubMed:29802199). Interacts with LYAR; this interaction impairs IRF3 DNA-binding activity (PubMed:31413131). Interacts with TRAF3 (PubMed:27980081). Interacts with ZDHHC11; ZDHHC11 recruits IRF3 to STING1 upon DNA virus infection and thereby promotes IRF3 activation (PubMed:28331227).</text>
</comment>
<comment type="subunit">
<text evidence="20 40">(Microbial infection) Interacts with rotavirus A NSP1 (via pLxIS motif); this interaction leads to the proteasome-dependent degradation of IRF3.</text>
</comment>
<comment type="subunit">
<text evidence="19">(Microbial infection) Interacts with herpes virus 8/HHV-8 protein VIRF1 (PubMed:11314014).</text>
</comment>
<comment type="subunit">
<text evidence="43">(Microbial infection) Interacts with Seneca Valley virus protease 3C; this interaction is involved in the suppression of IRF3 expression and phosphorylation by the virus.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2650369">
<id>Q14653</id>
</interactant>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2650369">
<id>Q14653</id>
</interactant>
<interactant intactId="EBI-5349621">
<id>Q9Y3R0</id>
<label>GRIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2650369">
<id>Q14653</id>
</interactant>
<interactant intactId="EBI-307369">
<id>Q14164</id>
<label>IKBKE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2650369">
<id>Q14653</id>
</interactant>
<interactant intactId="EBI-2650369">
<id>Q14653</id>
<label>IRF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2650369">
<id>Q14653</id>
</interactant>
<interactant intactId="EBI-3649340">
<id>Q9Y5Q3</id>
<label>MAFB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2650369">
<id>Q14653</id>
</interactant>
<interactant intactId="EBI-491274">
<id>P06400</id>
<label>RB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2650369">
<id>Q14653</id>
</interactant>
<interactant intactId="EBI-971402">
<id>P28749</id>
<label>RBL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2650369">
<id>Q14653</id>
</interactant>
<interactant intactId="EBI-1047061">
<id>O14730</id>
<label>RIOK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2650369">
<id>Q14653</id>
</interactant>
<interactant intactId="EBI-347996">
<id>O43765</id>
<label>SGTA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2650369">
<id>Q14653</id>
</interactant>
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
<label>TBK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2650369">
<id>Q14653</id>
</interactant>
<interactant intactId="EBI-25474079">
<id>PRO_0000037311</id>
<label>rep</label>
<dbReference type="UniProtKB" id="P0C6X7"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="16 45 57">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="16 45 57">Nucleus</location>
</subcellularLocation>
<text evidence="16">Shuttles between cytoplasmic and nuclear compartments, with export being the prevailing effect (PubMed:10805757). When activated, IRF3 interaction with CREBBP prevents its export to the cytoplasm (PubMed:10805757).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q14653-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q14653-2</id>
<name>2</name>
<sequence type="described" ref="VSP_043319"/>
</isoform>
<isoform>
<id>Q14653-3</id>
<name>3</name>
<sequence type="described" ref="VSP_046911 VSP_043319"/>
</isoform>
<isoform>
<id>Q14653-4</id>
<name>4</name>
<sequence type="described" ref="VSP_046912"/>
</isoform>
<isoform>
<id>Q14653-5</id>
<name>5</name>
<sequence type="described" ref="VSP_047690 VSP_047691"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Expressed constitutively in a variety of tissues.</text>
</comment>
<comment type="PTM">
<text evidence="34 35 36 37">Constitutively phosphorylated on many Ser/Thr residues (PubMed:22394562, PubMed:23478265, PubMed:23746807). Activated following phosphorylation by TBK1 and IKBKE (PubMed:23478265, PubMed:23746807, PubMed:25636800). Innate adapter protein MAVS, STING1 or TICAM1 are first activated by viral RNA, cytosolic DNA, and bacterial lipopolysaccharide (LPS), respectively, leading to activation of the kinases TBK1 and IKBKE (PubMed:25636800). These kinases then phosphorylate the adapter proteins on the pLxIS motif, leading to recruitment of IRF3, thereby licensing IRF3 for phosphorylation by TBK1 (PubMed:25636800). Phosphorylated IRF3 dissociates from the adapter proteins, dimerizes, and then enters the nucleus to induce IFNs (PubMed:25636800).</text>
</comment>
<comment type="PTM">
<text evidence="18">(Microbial infection) Phosphorylation and subsequent activation of IRF3 is inhibited by vaccinia virus protein E3.</text>
</comment>
<comment type="PTM">
<text evidence="30 31">Ubiquitinated; ubiquitination involves RBCK1 leading to proteasomal degradation. Polyubiquitinated; ubiquitination involves TRIM21 leading to proteasomal degradation.</text>
</comment>
<comment type="PTM">
<text evidence="30 31 33">ISGylated by HERC5 resulting in sustained IRF3 activation and in the inhibition of IRF3 ubiquitination by disrupting PIN1 binding. The phosphorylation state of IRF3 does not alter ISGylation.</text>
</comment>
<comment type="disease" evidence="38">
<disease id="DI-04529">
<name>Encephalopathy, acute, infection-induced, Herpes-specific, 7</name>
<acronym>IIAE7</acronym>
<description>A rare complication of human herpesvirus 1 (HHV-1) infection, occurring in only a small minority of HHV-1 infected individuals. It is characterized by hemorrhagic necrosis of parts of the temporal and frontal lobes. Onset is over several days and involves fever, headache, seizures, stupor, and often coma, frequently with a fatal outcome.</description>
<dbReference type="MIM" id="616532"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="15">Belongs to the IRF family.</text>
</comment>
<dbReference type="EMBL" id="Z56281">
<property type="protein sequence ID" value="CAA91227.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB102884">
<property type="protein sequence ID" value="BAD89413.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB102886">
<property type="protein sequence ID" value="BAD89415.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB102887">
<property type="protein sequence ID" value="BAD89416.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292027">
<property type="protein sequence ID" value="BAF84716.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314421">
<property type="protein sequence ID" value="BAG37040.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC011495">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471177">
<property type="protein sequence ID" value="EAW52510.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000660">
<property type="protein sequence ID" value="AAH00660.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC071721">
<property type="protein sequence ID" value="AAH71721.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U86636">
<property type="protein sequence ID" value="AAC68818.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12775.1">
<molecule id="Q14653-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56099.1">
<molecule id="Q14653-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS59407.1">
<molecule id="Q14653-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS59409.1">
<molecule id="Q14653-4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001184051.1">
<molecule id="Q14653-4"/>
<property type="nucleotide sequence ID" value="NM_001197122.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001184052.1">
<property type="nucleotide sequence ID" value="NM_001197123.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001184053.1">
<molecule id="Q14653-2"/>
<property type="nucleotide sequence ID" value="NM_001197124.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001184054.1">
<property type="nucleotide sequence ID" value="NM_001197125.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001184055.1">
<property type="nucleotide sequence ID" value="NM_001197126.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001184056.1">
<molecule id="Q14653-3"/>
<property type="nucleotide sequence ID" value="NM_001197127.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001184057.1">
<molecule id="Q14653-3"/>
<property type="nucleotide sequence ID" value="NM_001197128.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001562.1">
<molecule id="Q14653-1"/>
<property type="nucleotide sequence ID" value="NM_001571.5"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006723260.1">
<molecule id="Q14653-4"/>
<property type="nucleotide sequence ID" value="XM_006723197.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006723261.1">
<molecule id="Q14653-4"/>
<property type="nucleotide sequence ID" value="XM_006723198.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016882255.1">
<molecule id="Q14653-1"/>
<property type="nucleotide sequence ID" value="XM_017026766.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016882256.1">
<molecule id="Q14653-1"/>
<property type="nucleotide sequence ID" value="XM_017026767.1"/>
</dbReference>
<dbReference type="PDB" id="1J2F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=175-427"/>
</dbReference>
<dbReference type="PDB" id="1QWT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=173-427"/>
</dbReference>
<dbReference type="PDB" id="1T2K">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=1-112"/>
</dbReference>
<dbReference type="PDB" id="1ZOQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.37"/>
<property type="chains" value="A/B=196-386"/>
</dbReference>
<dbReference type="PDB" id="2O61">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=9-111"/>
</dbReference>
<dbReference type="PDB" id="2O6G">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="E/F/G/H=1-123"/>
</dbReference>
<dbReference type="PDB" id="2PI0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B/C/D=1-113"/>
</dbReference>
<dbReference type="PDB" id="3A77">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B/C/D=189-427"/>
</dbReference>
<dbReference type="PDB" id="3QU6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C=1-113"/>
</dbReference>
<dbReference type="PDB" id="5JEJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=189-427"/>
</dbReference>
<dbReference type="PDB" id="5JEK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=189-427"/>
</dbReference>
<dbReference type="PDB" id="5JEL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=189-427"/>
</dbReference>
<dbReference type="PDB" id="5JEM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/E/G=189-398"/>
</dbReference>
<dbReference type="PDB" id="5JEO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.72"/>
<property type="chains" value="A=189-427"/>
</dbReference>
<dbReference type="PDB" id="5JER">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.91"/>
<property type="chains" value="A/C/E/G=189-427"/>
</dbReference>
<dbReference type="PDB" id="6SIV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=137-148"/>
</dbReference>
<dbReference type="PDB" id="6SJA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=137-148"/>
</dbReference>
<dbReference type="PDBsum" id="1J2F"/>
<dbReference type="PDBsum" id="1QWT"/>
<dbReference type="PDBsum" id="1T2K"/>
<dbReference type="PDBsum" id="1ZOQ"/>
<dbReference type="PDBsum" id="2O61"/>
<dbReference type="PDBsum" id="2O6G"/>
<dbReference type="PDBsum" id="2PI0"/>
<dbReference type="PDBsum" id="3A77"/>
<dbReference type="PDBsum" id="3QU6"/>
<dbReference type="PDBsum" id="5JEJ"/>
<dbReference type="PDBsum" id="5JEK"/>
<dbReference type="PDBsum" id="5JEL"/>
<dbReference type="PDBsum" id="5JEM"/>
<dbReference type="PDBsum" id="5JEO"/>
<dbReference type="PDBsum" id="5JER"/>
<dbReference type="PDBsum" id="6SIV"/>
<dbReference type="PDBsum" id="6SJA"/>
<dbReference type="SMR" id="Q14653"/>
<dbReference type="BioGRID" id="109869">
<property type="interactions" value="98"/>
</dbReference>
<dbReference type="CORUM" id="Q14653"/>
<dbReference type="DIP" id="DIP-41448N"/>
<dbReference type="ELM" id="Q14653"/>
<dbReference type="IntAct" id="Q14653">
<property type="interactions" value="58"/>
</dbReference>
<dbReference type="MINT" id="Q14653"/>
<dbReference type="STRING" id="9606.ENSP00000471896"/>
<dbReference type="iPTMnet" id="Q14653"/>
<dbReference type="PhosphoSitePlus" id="Q14653"/>
<dbReference type="BioMuta" id="IRF3"/>
<dbReference type="DMDM" id="2497442"/>
<dbReference type="EPD" id="Q14653"/>
<dbReference type="jPOST" id="Q14653"/>
<dbReference type="MassIVE" id="Q14653"/>
<dbReference type="MaxQB" id="Q14653"/>
<dbReference type="PaxDb" id="Q14653"/>
<dbReference type="PeptideAtlas" id="Q14653"/>
<dbReference type="PRIDE" id="Q14653"/>
<dbReference type="ProteomicsDB" id="60091">
<molecule id="Q14653-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60092">
<molecule id="Q14653-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="62791"/>
<dbReference type="Antibodypedia" id="1283">
<property type="antibodies" value="1295 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3661"/>
<dbReference type="Ensembl" id="ENST00000309877">
<molecule id="Q14653-1"/>
<property type="protein sequence ID" value="ENSP00000310127"/>
<property type="gene ID" value="ENSG00000126456"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000377139">
<molecule id="Q14653-1"/>
<property type="protein sequence ID" value="ENSP00000366344"/>
<property type="gene ID" value="ENSG00000126456"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000442265">
<molecule id="Q14653-5"/>
<property type="protein sequence ID" value="ENSP00000400378"/>
<property type="gene ID" value="ENSG00000126456"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000596765">
<molecule id="Q14653-3"/>
<property type="protein sequence ID" value="ENSP00000470512"/>
<property type="gene ID" value="ENSG00000126456"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000597198">
<molecule id="Q14653-1"/>
<property type="protein sequence ID" value="ENSP00000469113"/>
<property type="gene ID" value="ENSG00000126456"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000599223">
<molecule id="Q14653-2"/>
<property type="protein sequence ID" value="ENSP00000471358"/>
<property type="gene ID" value="ENSG00000126456"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000600022">
<molecule id="Q14653-3"/>
<property type="protein sequence ID" value="ENSP00000472700"/>
<property type="gene ID" value="ENSG00000126456"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000601291">
<molecule id="Q14653-4"/>
<property type="protein sequence ID" value="ENSP00000471896"/>
<property type="gene ID" value="ENSG00000126456"/>
</dbReference>
<dbReference type="GeneID" id="3661"/>
<dbReference type="KEGG" id="hsa:3661"/>
<dbReference type="UCSC" id="uc002pot.3">
<molecule id="Q14653-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3661"/>
<dbReference type="DisGeNET" id="3661"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000126456.15"/>
<dbReference type="GeneCards" id="IRF3"/>
<dbReference type="HGNC" id="HGNC:6118">
<property type="gene designation" value="IRF3"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000126456">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="IRF3"/>
<dbReference type="MIM" id="603734">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616532">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14653"/>
<dbReference type="OpenTargets" id="ENSG00000126456"/>
<dbReference type="PharmGKB" id="PA29917"/>
<dbReference type="eggNOG" id="ENOG502QTRR">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160569"/>
<dbReference type="HOGENOM" id="CLU_031544_2_0_1"/>
<dbReference type="InParanoid" id="Q14653"/>
<dbReference type="KO" id="K05411"/>
<dbReference type="OMA" id="QTVFCPR"/>
<dbReference type="OrthoDB" id="648909at2759"/>
<dbReference type="PhylomeDB" id="Q14653"/>
<dbReference type="TreeFam" id="TF328512"/>
<dbReference type="PathwayCommons" id="Q14653"/>
<dbReference type="Reactome" id="R-HSA-1169408">
<property type="pathway name" value="ISG15 antiviral mechanism"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1606341">
<property type="pathway name" value="IRF3 mediated activation of type 1 IFN"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3134973">
<property type="pathway name" value="LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3134975">
<property type="pathway name" value="Regulation of innate immune responses to cytosolic DNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3270619">
<property type="pathway name" value="IRF3-mediated induction of type I IFN"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-877300">
<property type="pathway name" value="Interferon gamma signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9013973">
<property type="pathway name" value="TICAM1-dependent activation of IRF3/IRF7"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-909733">
<property type="pathway name" value="Interferon alpha/beta signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-918233">
<property type="pathway name" value="TRAF3-dependent IRF activation pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933541">
<property type="pathway name" value="TRAF6 mediated IRF7 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936440">
<property type="pathway name" value="Negative regulators of DDX58/IFIH1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936964">
<property type="pathway name" value="Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"/>
</dbReference>
<dbReference type="SIGNOR" id="Q14653"/>
<dbReference type="BioGRID-ORCS" id="3661">
<property type="hits" value="5 hits in 894 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IRF3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q14653"/>
<dbReference type="GeneWiki" id="IRF3"/>
<dbReference type="GenomeRNAi" id="3661"/>
<dbReference type="Pharos" id="Q14653">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q14653"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="Q14653">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000126456">
<property type="expression patterns" value="Expressed in granulocyte and 221 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q14653">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14653">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071360">
<property type="term" value="P:cellular response to exogenous dsRNA"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002376">
<property type="term" value="P:immune system process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060333">
<property type="term" value="P:interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031663">
<property type="term" value="P:lipopolysaccharide-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071888">
<property type="term" value="P:macrophage apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0039530">
<property type="term" value="P:MDA-5 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032480">
<property type="term" value="P:negative regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050715">
<property type="term" value="P:positive regulation of cytokine secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032727">
<property type="term" value="P:positive regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060340">
<property type="term" value="P:positive regulation of type I interferon-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097300">
<property type="term" value="P:programmed necrotic cell death"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032479">
<property type="term" value="P:regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032606">
<property type="term" value="P:type I interferon production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060337">
<property type="term" value="P:type I interferon signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd00103">
<property type="entry name" value="IRF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP01614"/>
<dbReference type="Gene3D" id="1.10.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.200.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00079"/>
<dbReference type="InterPro" id="IPR019817">
<property type="entry name" value="Interferon_reg_fac_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001346">
<property type="entry name" value="Interferon_reg_fact_DNA-bd_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR019471">
<property type="entry name" value="Interferon_reg_factor-3"/>
</dbReference>
<dbReference type="InterPro" id="IPR017855">
<property type="entry name" value="SMAD-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR008984">
<property type="entry name" value="SMAD_FHA_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036388">
<property type="entry name" value="WH-like_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036390">
<property type="entry name" value="WH_DNA-bd_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11949">
<property type="entry name" value="PTHR11949"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00605">
<property type="entry name" value="IRF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF10401">
<property type="entry name" value="IRF-3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00267">
<property type="entry name" value="INTFRNREGFCT"/>
</dbReference>
<dbReference type="SMART" id="SM00348">
<property type="entry name" value="IRF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01243">
<property type="entry name" value="IRF-3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46785">
<property type="entry name" value="SSF46785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49879">
<property type="entry name" value="SSF49879"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00601">
<property type="entry name" value="IRF_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51507">
<property type="entry name" value="IRF_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Interferon regulatory factor 3" id="PRO_0000154553">
<location>
<begin position="1"/>
<end position="427"/>
</location>
</feature>
<feature type="DNA-binding region" description="IRF tryptophan pentad repeat" evidence="15">
<location>
<begin position="5"/>
<end position="111"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with ZDHHC11" evidence="42">
<location>
<begin position="141"/>
<end position="427"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HERC5" evidence="33">
<location>
<begin position="200"/>
<end position="360"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal">
<location>
<begin position="139"/>
<end position="149"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="151"/>
<end position="191"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="36">
<location>
<position position="3"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="36">
<location>
<position position="14"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="36">
<location>
<position position="75"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="36">
<location>
<position position="97"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="123"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="36">
<location>
<position position="180"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="36">
<location>
<position position="188"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="36">
<location>
<position position="237"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="36">
<location>
<position position="244"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="36">
<location>
<position position="253"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="34">
<location>
<position position="385"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1" evidence="34 36 40">
<location>
<position position="386"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKE and TBK1" evidence="34 35 40">
<location>
<position position="396"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="36">
<location>
<position position="398"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="36">
<location>
<position position="404"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="36">
<location>
<position position="427"/>
</location>
</feature>
<feature type="disulfide bond" evidence="23 24">
<location>
<begin position="267"/>
<end position="289"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15)" evidence="33">
<location>
<position position="193"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15)" evidence="33">
<location>
<position position="360"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15)" evidence="33">
<location>
<position position="366"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_046911" evidence="55">
<location>
<begin position="1"/>
<end position="146"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_047690" evidence="55">
<original>AWAEATGAYVPGRDKPDLPTWKRNFRSALNRKEGLRLAEDRSKDPHDPH</original>
<variation>ELGTFPSQTPLRTPMVEAVLLIPRKTFWMSYWVTWCWPHSQIRDPQAWL</variation>
<location>
<begin position="56"/>
<end position="104"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_047691" evidence="55">
<location>
<begin position="105"/>
<end position="427"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_043319" evidence="55">
<location>
<begin position="201"/>
<end position="327"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_046912" evidence="49">
<original>DLITFTEGSGRSPRYALWFCVGESWPQDQPWTKRLVMVKVVPTCLRALVEMARVGGASSLENTVDLHISNSHPLSLTSDQYKAYLQDLVEGMDFQGPGES</original>
<variation>GSWAPRSDYLHGRKRTLTTLCPLVLCGGVMAPGPAVDQEARDGQGCAHVPQGLGRNGPGRGCLLPGEYCGPAHFQQPPTLPHLRPVQGLPAGLGGGHGFPGPWGELSPRSSWCASNPPVPHHLNQ</variation>
<location>
<begin position="328"/>
<end position="427"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs968457." id="VAR_011901">
<original>R</original>
<variation>Q</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34745118." id="VAR_049643">
<original>Y</original>
<variation>F</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In IIAE7; loss of viral infection-induced phosphorylation at S-386; loss of viral infection-induced homodimerization; loss of viral infection-induced transcription factor activity; unable to activate interferon transcription in response to viral infection; dbSNP:rs750526659." id="VAR_075805" evidence="38">
<original>R</original>
<variation>Q</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1049486." id="VAR_011902">
<original>E</original>
<variation>K</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7251." id="VAR_011903" evidence="25 47">
<original>S</original>
<variation>T</variation>
<location>
<position position="427"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes nuclear localization." evidence="16">
<original>KR</original>
<variation>NG</variation>
<location>
<begin position="77"/>
<end position="78"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on subcellular localization." evidence="16">
<original>RK</original>
<variation>LQ</variation>
<location>
<begin position="86"/>
<end position="87"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes nuclear export." evidence="16">
<original>IL</original>
<variation>MM</variation>
<location>
<begin position="139"/>
<end position="140"/>
</location>
</feature>
<feature type="mutagenesis site" description="Highly diminished ISGylation; when associated with R-360 and R-366." evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished interaction with STING1, MAVS or TICAM1." evidence="40">
<original>R</original>
<variation>S</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with TICAM1." evidence="40">
<original>H</original>
<variation>S</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with TICAM1." evidence="40">
<original>H</original>
<variation>S</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished interaction with STING1, MAVS or TICAM1." evidence="40">
<original>K</original>
<variation>S</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="mutagenesis site" description="Highly diminished ISGylation; when associated with R-193 and R-366." evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="mutagenesis site" description="Highly diminished ISGylation; when associated with R-193 and R-360." evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of viral infection induced phosphorylation." evidence="46">
<original>SS</original>
<variation>AA</variation>
<location>
<begin position="385"/>
<end position="386"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of viral infection induced phosphorylation." evidence="17 34 37">
<original>S</original>
<variation>A</variation>
<variation>D</variation>
<variation>E</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of viral infection induced phosphorylation." evidence="17 34 36 37">
<original>S</original>
<variation>A</variation>
<variation>D</variation>
<variation>E</variation>
<location>
<position position="386"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant; interacts with CREBBP; when associated with E-396." evidence="40">
<original>S</original>
<variation>E</variation>
<location>
<position position="386"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of viral infection induced phosphorylation." evidence="46">
<original>SNSHPLSLTS</original>
<variation>ANAHPLALAA</variation>
<location>
<begin position="396"/>
<end position="405"/>
</location>
</feature>
<feature type="mutagenesis site" description="Acts as a constitutively activated IRF3." evidence="46">
<original>SNSHPLSLTS</original>
<variation>DNDHPLDLDD</variation>
<location>
<begin position="396"/>
<end position="405"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of viral infection induced phosphorylation.">
<original>SNS</original>
<variation>ANA</variation>
<location>
<begin position="396"/>
<end position="398"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant; interacts with CREBBP; when associated with E-386." evidence="40">
<original>S</original>
<variation>E</variation>
<location>
<position position="396"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of viral infection induced phosphorylation.">
<original>SLTS</original>
<variation>ALAA</variation>
<location>
<begin position="402"/>
<end position="405"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG37040." ref="3" evidence="56">
<original>L</original>
<variation>F</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="8"/>
<end position="18"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="25"/>
<end position="27"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="28"/>
<end position="31"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="33"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="41"/>
<end position="45"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="49"/>
<end position="51"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="53"/>
<end position="60"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="66"/>
<end position="69"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="73"/>
<end position="85"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="90"/>
<end position="96"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="100"/>
<end position="102"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="104"/>
<end position="109"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="137"/>
<end position="143"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="191"/>
<end position="196"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="204"/>
<end position="210"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="213"/>
<end position="220"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="226"/>
<end position="229"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="238"/>
<end position="244"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="248"/>
<end position="250"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="252"/>
<end position="254"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="255"/>
<end position="266"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="267"/>
<end position="270"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="272"/>
<end position="277"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="280"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="287"/>
<end position="289"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="291"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="304"/>
<end position="306"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="308"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="313"/>
<end position="315"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="317"/>
<end position="321"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="322"/>
<end position="333"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="343"/>
<end position="350"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="354"/>
<end position="356"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="358"/>
<end position="360"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="361"/>
<end position="369"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="370"/>
<end position="383"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="384"/>
<end position="391"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="395"/>
<end position="397"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="401"/>
<end position="404"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="405"/>
<end position="417"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ZOQ"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2O61"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2O6G"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PI0"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3A77"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3QU6"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JEJ"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JEK"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JEL"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JEM"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JEO"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JER"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6SJA"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P70671"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00840"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10805757"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10920266"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11124948"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11314014"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12186937"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12471095"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14517278"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14555995"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14555996"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14739303"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16153868"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16154084"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16281057"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18641315"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18711448"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19557502"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20308324"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22394562"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23478265"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23746807"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25636800"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26216125"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26347139"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27302953"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27980081"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28331227"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29427864"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29802199"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31413131"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9566918"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="48" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11846977"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16846591"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16979567"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="20049431"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9566918"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9803267"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="56" type="ECO:0000305"/>
<evidence key="57" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="25636800"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:6118"/>
</source>
</evidence>
<sequence length="427" mass="47219" checksum="F536676FA78B0110" modified="1997-11-01" version="1">MGTPKPRILPWLVSQLDLGQLEGVAWVNKSRTRFRIPWKHGLRQDAQQEDFGIFQAWAEATGAYVPGRDKPDLPTWKRNFRSALNRKEGLRLAEDRSKDPHDPHKIYEFVNSGVGDFSQPDTSPDTNGGGSTSDTQEDILDELLGNMVLAPLPDPGPPSLAVAPEPCPQPLRSPSLDNPTPFPNLGPSENPLKRLLVPGEEWEFEVTAFYRGRQVFQQTISCPEGLRLVGSEVGDRTLPGWPVTLPDPGMSLTDRGVMSYVRHVLSCLGGGLALWRAGQWLWAQRLGHCHTYWAVSEELLPNSGHGPDGEVPKDKEGGVFDLGPFIVDLITFTEGSGRSPRYALWFCVGESWPQDQPWTKRLVMVKVVPTCLRALVEMARVGGASSLENTVDLHISNSHPLSLTSDQYKAYLQDLVEGMDFQGPGES</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

